|
Antibody Drug Conjugates (ADCs) are composed of a payload (small molecule) linked to a monoclonal antibody (biomolecule) via a linker. ADCs are heterogeneous compounds, and more complex than unmodified monoclonal antibodies: to run analyses, a cross-functional understanding of both biologicals and small molecules is needed. Then, the appropriate analytical equipment - such as a mass spectrometer - is required to allow advanced characterization of these bioconjugates. With 90% in-house analysis, Novasep’s QC experts have developed an internal platform method for fast ADC characterization. The method, presented in this case study, is now used for customer projects.
|
> How ADC characterization using LC-MSE allows the analysis of multiple attributes in one analysis run
> How LC-MSE allows the detection of post-translational modifications, disulfide bridges and conjugation sites